0
0 (0%)
Nuo Therapeutics, Inc. [AURX]
Source:
Company Overview
Nuo is a regenerative therapies company developing and marketing products primarily within the U.S. We commercialize innovative cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing. The use of autologous (i.e., from self or the patient’s own) biological therapies for tissue repair and regeneration is part of a transformative clinical strategy designed to improve long-term recovery in complex chronic conditions with significant unmet medical needs.
| Country | United States |
| Headquarters | houston, texas |
| Phone Number | 832-236-9060 |
| Industry | manufacturing |
| CEO | David E. Jorden |
| Website | nuot.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $1.4 |
| Operating Profit | $-2.5 |
| Net Income | $-2.3 |
| Net Cash | $-0.6 |
Profit Ratios
| Gross Margin | $1.1 |
| Operating Margin | -180 |
| Profit as % of Revenues | -45.7% |
| Profit as % of Assets | -151.5% |
| Profit as % of Stockholder Equity | -452.3% |
Management Effectiveness
| Return on Equity | -452.3% |
| Return on Assets | -195.4% |
| Turnover Ratio | 89% |
| EBITA | $-2.5 |
Balance Sheet and Cash Flow Measures
| Total Assets | $1.2 |
| Total Liabilities | $0.7 |
| Operating Cash Flow | $-2.2 |
| Investing Cash Flow | $-0.2 |
| Financing Cash Flow | $1.7 |
